Hims & Hers Health Inc Ordinary Shares - Class A
HIMS: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| HH? | LOCK|%$< | LOCK|<<cF%By |
Hims Sees Margin Compression From Mix Shift and New Markets As Long-Term Targets Appear Lofty
Business Strategy and Outlook
Hims & Hers is one of the leading telehealth firms in the US. Since its 2017 launch, the platform has connected patients with healthcare providers across specialties including erectile dysfunction, hair loss, and weight loss. Subscribers have soared from 290,000 at the end of 2020 to over 2.7 million in 2026, with roughly half of the growth driven by the late-2023 launch of the weight-loss program.
